Cargando…

A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study

INTRODUCTION: Dermal papilla (DP) is the site of expression of various hair growth related genes. Various researches have demonstrated the underlying importance of Wnt proteins and wound growth factors in stimulating DP associated stem cells. Microneedling works by stimulation of stem cells and indu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhurat, Rachita, Sukesh, MS, Avhad, Ganesh, Dandale, Ameet, Pal, Anjali, Pund, Poonam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746236/
https://www.ncbi.nlm.nih.gov/pubmed/23960389
http://dx.doi.org/10.4103/0974-7753.114700
_version_ 1782280812860801024
author Dhurat, Rachita
Sukesh, MS
Avhad, Ganesh
Dandale, Ameet
Pal, Anjali
Pund, Poonam
author_facet Dhurat, Rachita
Sukesh, MS
Avhad, Ganesh
Dandale, Ameet
Pal, Anjali
Pund, Poonam
author_sort Dhurat, Rachita
collection PubMed
description INTRODUCTION: Dermal papilla (DP) is the site of expression of various hair growth related genes. Various researches have demonstrated the underlying importance of Wnt proteins and wound growth factors in stimulating DP associated stem cells. Microneedling works by stimulation of stem cells and inducing activation of growth factors. MATERIALS AND METHODS: Hundred cases of mild to moderate (III vertex or IV) androgenetic alopecia (AGA) were recruited into 2 groups. After randomization one group was offered weekly microneedling treatment with twice daily 5% minoxidil lotion (Microneedling group); other group was given only 5% minoxidil lotion. After baseline global photographs, the scalp were shaved off to ensure equal length of hair shaft in all. Hair count was done in 1 cm(2) targeted fixed area (marked with tattoo) at baseline and at end of therapy (week 12). The 3 primary efficacy parameters assessed were: Change from baseline hair count at 12 weeks, patient assessment of hair growth at 12 weeks, and investigator assessment of hair growth at 12 weeks. A blinded investigators evaluated global photographic response. The response was assessed by 7- point scale. RESULTS: (1) Hair counts – The mean change in hair count at week 12 was significantly greater for the Microneedling group compared to the Minoxidil group (91.4 vs 22.2 respectively). (2) Investigator evaluation – Forty patients in Microneedling group had +2 to +3 response on 7-point visual analogue scale, while none showed the same response in the Minoxidil group. (3) Patient evaluation – In the Microneedling group, 41 (82%) patients reported more than 50% improvement versus only 2 (4.5%) patients in the Minoxidil group. Unsatisfied patients to conventional therapy for AGA got good response with Microneedling treatment. CONCLUSION: Dermaroller along with Minoxidil treated group was statistically superior to Minoxidil treated group in promoting hair growth in men with AGA for all 3 primary efficacy measures of hair growth. Microneedling is a safe and a promising tool in hair stimulation and also is useful to treat hair loss refractory to Minoxidil therapy.
format Online
Article
Text
id pubmed-3746236
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37462362013-08-19 A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study Dhurat, Rachita Sukesh, MS Avhad, Ganesh Dandale, Ameet Pal, Anjali Pund, Poonam Int J Trichology Original Article INTRODUCTION: Dermal papilla (DP) is the site of expression of various hair growth related genes. Various researches have demonstrated the underlying importance of Wnt proteins and wound growth factors in stimulating DP associated stem cells. Microneedling works by stimulation of stem cells and inducing activation of growth factors. MATERIALS AND METHODS: Hundred cases of mild to moderate (III vertex or IV) androgenetic alopecia (AGA) were recruited into 2 groups. After randomization one group was offered weekly microneedling treatment with twice daily 5% minoxidil lotion (Microneedling group); other group was given only 5% minoxidil lotion. After baseline global photographs, the scalp were shaved off to ensure equal length of hair shaft in all. Hair count was done in 1 cm(2) targeted fixed area (marked with tattoo) at baseline and at end of therapy (week 12). The 3 primary efficacy parameters assessed were: Change from baseline hair count at 12 weeks, patient assessment of hair growth at 12 weeks, and investigator assessment of hair growth at 12 weeks. A blinded investigators evaluated global photographic response. The response was assessed by 7- point scale. RESULTS: (1) Hair counts – The mean change in hair count at week 12 was significantly greater for the Microneedling group compared to the Minoxidil group (91.4 vs 22.2 respectively). (2) Investigator evaluation – Forty patients in Microneedling group had +2 to +3 response on 7-point visual analogue scale, while none showed the same response in the Minoxidil group. (3) Patient evaluation – In the Microneedling group, 41 (82%) patients reported more than 50% improvement versus only 2 (4.5%) patients in the Minoxidil group. Unsatisfied patients to conventional therapy for AGA got good response with Microneedling treatment. CONCLUSION: Dermaroller along with Minoxidil treated group was statistically superior to Minoxidil treated group in promoting hair growth in men with AGA for all 3 primary efficacy measures of hair growth. Microneedling is a safe and a promising tool in hair stimulation and also is useful to treat hair loss refractory to Minoxidil therapy. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3746236/ /pubmed/23960389 http://dx.doi.org/10.4103/0974-7753.114700 Text en Copyright: © International Journal of Trichology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Dhurat, Rachita
Sukesh, MS
Avhad, Ganesh
Dandale, Ameet
Pal, Anjali
Pund, Poonam
A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study
title A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study
title_full A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study
title_fullStr A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study
title_full_unstemmed A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study
title_short A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study
title_sort randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746236/
https://www.ncbi.nlm.nih.gov/pubmed/23960389
http://dx.doi.org/10.4103/0974-7753.114700
work_keys_str_mv AT dhuratrachita arandomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT sukeshms arandomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT avhadganesh arandomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT dandaleameet arandomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT palanjali arandomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT pundpoonam arandomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT dhuratrachita randomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT sukeshms randomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT avhadganesh randomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT dandaleameet randomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT palanjali randomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy
AT pundpoonam randomizedevaluatorblindedstudyofeffectofmicroneedlinginandrogeneticalopeciaapilotstudy